Clinical Trial Update: Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen to Expedite Product Availability in Perioperative Bleeding [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating transfusion of pathogen-reduced cryoprecipitated fibrinogen to expedite management of perioperative bleeding due to hypofibrinogenemia;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding
• Hypofibrinogenemia

Drugs mentioned

• Pathogen-reduced cryoprecipitated fibrinogen (Cryoprecipitated fibrinogen (pathogen-reduced))

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Hypofibrinogenemia, Bleeding | Phase 4 | Status: COMPLETED | Results posted: 2025-11-21